Qualification & Validation
Qualification & Validation
Quality Assurance
Quality Assurance
Regulatory Affairs
Regulatory Affairs
Clinical
Clinical
Lab Services
Lab Services
Vigilance
Vigilance
Software Solutions & Services
Software Solutions & Services
Tox green
Toxicology
Pharma (2)
Pharma & Biotech
Medical Devices (2)
Medical devices
IVD (2)
In vitro diagnostics
Search QbD Group
  • There are no suggestions because the search field is empty.
Safety Signal Program - Vigilance - QbD Group

Safety Signal Program

Proactive safety signal detection for better patient outcomes

Effective signal detection is key to identifying potential safety issues early and protecting patient health. At QbD Group, our Safety Signal Program leverages a wide array of data sources, including spontaneous reports, clinical studies, scientific literature, and the EudraVigilance database. This proactive and comprehensive approach ensures timely detection and management of safety signals, helping you maintain regulatory compliance and build trust in your product.

Read more

What is a safety signal program?

A safety signal program is a systematic process for identifying and analyzing potential safety concerns related to medicinal products. By monitoring a variety of data sources, the program detects trends or patterns that might indicate risks, enabling prompt action to mitigate harm and enhance product safety. Key components of a safety signal program:

  • Data collection: Gathering information from diverse sources, including spontaneous reports, clinical trials, and scientific literature.
  • Signal detection: Identifying trends or patterns using advanced analytical tools and methodologies.
  • Risk assessment: Evaluating the significance and impact of detected signals.
  • Regulatory reporting: Communicating findings to relevant authorities in a compliant and timely manner.
  • Actionable insights: Providing recommendations for risk mitigation or further investigation.

Discover why a safety signal program is essential

Safety Signal Program - Vigilance - QbD Group (2)

Why is a safety signal program essential?

A robust safety signal program is critical for safeguarding patient health and ensuring the continued success of your product. Here’s why it matters:

 

  • Timely risk identification: Early detection of potential safety issues prevents escalation and reduces harm.

  • Regulatory compliance: Ensure adherence to global pharmacovigilance standards.

  • Enhanced product safety: Strengthen the safety profile of your medicinal products.

  • Data-driven decision-making: Leverage insights from signal detection to make informed safety decisions.

  • Stakeholder confidence: Build trust with regulators, healthcare providers, and patients.

 

Discover how we can support you

How can we help?

QbD Group’s Safety Signal Program offers end-to-end support for proactive signal detection and management:

Comprehensive data sources

Comprehensive data sources

Utilizing spontaneous reports, clinical trials, scientific literature, and regulatory databases like EudraVigilance.

Advanced methodologies

Advanced methodologies

Employing state-of-the-art tools for trend analysis and signal identification.

Expert risk assessment

Expert risk assessment

Evaluating and classifying signals to determine their clinical significance.

Regulatory submissions

Regulatory submissions

Preparing and submitting reports in compliance with EMA, FDA, and other global standards.

Custom solutions

Custom solutions

Tailoring workflows to meet the unique needs of your product portfolio and market.

Safety Signal Program - Vigilance - QbD Group (1)

Why partner with QbD Group?

Choosing QbD Group for your Safety Signal Program provides:

  • Proactive monitoring: A dedicated team of experts continuously monitoring diverse data sources for potential safety signals.

  • Global expertise: Decades of experience in pharmacovigilance and regulatory compliance.

  • Tailored strategies: Custom workflows designed to align with your operational needs and goals.

  • Comprehensive support: From signal detection to regulatory submissions, we’re with you every step of the way.

Contact us
doc-mask

Related content

preview_image
Blog

Establishing and Maintaining the Right Level of Clinical Evidence under the EU IVDR

We’re proud to highlight a new publication by Pieter Bogaert, PhD—senior...
Read more
preview_image
Blog

Post-Market Surveillance (PMS) and Post-Market Clinical Follow-Up (PMCF) under the MDR: Ensuring safety and performance

With the introduction of the Medical Device Regulation (MDR), the...
Read more
preview_image
Blog

What Makes Usability Testing Crucial for Near-Patient and Self-Testing Devices under IVDR?

It shouldn’t be a surprise that today, “Near-Patient Testing (NPT)” and...
Read more
preview_image
Blog

When does Annex XIV apply in Performance Studies, and what key documentation is needed for compliance?

In the European regulatory landscape, conducting performance studies for in...
Read more
Discover all
contact-mail

Get in touch

Ready to enhance your safety signal detection?

QbD Group’s Safety Signal Program combines proactive monitoring and expert analysis to ensure timely detection of safety concerns and regulatory compliance. Contact us today to learn more.

Vigilance_Get in touch